within Pharmacolibrary.Drugs.R_RespiratorySystem.R05D_CoughSuppressantsExclCombinationsWithExpectorants.R05DB15_Zipeprol;

model Zipeprol
  extends Pharmacolibrary.Drugs.ATC.R.R05DB15;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>R05DB15</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Zipeprol is a centrally acting antitussive (cough suppressant) that was previously used for the symptomatic relief of cough. It is no longer approved or widely used due to its potential for abuse and adverse effects including fatal intoxications.</p><h4>Pharmacokinetics</h4><p>No original human pharmacokinetic data for zipeprol is directly available in published literature. The following parameters are rough theoretical estimates based on similar antitussive agents.</p><h4>References</h4><ol><li><p>Constantin, M, &amp; Pognat, JF (1978). Zipeprol metabolism in man and in the animal. <i>Arzneimittel-Forschung</i> 28(1) 64–72. PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/580201/\">https://pubmed.ncbi.nlm.nih.gov/580201</a></p></li><li><p>Gielsdorf, W, &amp; Toffel-Nadolny, P (1981). [Biotransformation of zipeprol (Mirsol) in humans. Gas chromatographic/mass spectrometric studies, using ammonia as a selective reactant gas (author&#x27;s transl)]. <i>Journal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie</i> 19(1) 25–30. PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/7205156/\">https://pubmed.ncbi.nlm.nih.gov/7205156</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Zipeprol;
